Eating breakfast burns more carbs during exercise and accelerates metabolism for next meal [News Release]

Health and Medical News and Resources

From the University of Bath, August 18, 2018 news release


“Eating breakfast before exercise may “prime” the body to burn carbohydrates during exercise and more rapidly digest food after working out, University researchers have found.

Scientists from our Department for Health, working with colleagues at the universities of Birmingham, Newcastle and Stirling, were studying the effect of eating breakfast versus fasting overnight before an hour’s cycling. In a control test breakfast was followed by three hours’ rest.

The volunteers ate a breakfast of porridge made with milk two hours before exercise.

Post exercise or rest, the researchers tested the blood glucose levels and muscle glycogen levels of the 12 healthy male volunteers who took part. They discovered that eating breakfast increased the rate at which the body burned carbohydrates during exercise, as well as increasing the rate the body digested and metabolised food eaten after exercise too.”


View original post 5 more words


FDA Will Propose New Regulations for E-Cigarettes

Medication Health News

dstockzlaja-i-pedjaset2pedja-no-2stock-4-100229272The FDA has now begun making its proposals to regulated the multibillion dollar e-cigarette business as well as other tobacco products. In doing so, they will be standardization of products that is not currently present in the market as well as need for labeling for all nicotine containing products. There are fears that these regulations could stymie ingenuity in the growing market causing only the bigger players to profit. How will the changes in e-cigarettes affect the smoking habits of the population?

For additional information, please see the article in New York Times.

Image courtesy of [patrisyu]/FreeDigitalPhotos.Net

View original post

The Steep cost of Life Saving Drugs

Medication Health News

ID-10057221 With many new drugs being brought to market, there has been increased talk about the pricing of many agents. Today, drugs in question include Evzio, a new naloxone auto-injector and  Sovaldi, a new antiviral for hepatitis C. These agents could save many lives, but their potential high costs could be a barrier to many of the patients of need. How should we solve this dilemma?  Should the subsidies be provided to those in need of these therapies?  What are your thoughts?

For additional information, please see the news analysis in the New York Times.

Image courtesy of [ddpavumba]/FreeDigitalPhotos.Net

View original post

FDA Weights Over-The-Counter Approval of Singulair

Medication Health News

ID-10095447May 2nd , the FDA will be discussing the use of Merck’s drug Singulair (montelukast) as another allergy medication available over-the-counter. Some of the discussions will be about the proper labeling of adverse events and the exclusive indication for allergy in adults. Currently half of the prescriptions for Singulair are for asthma and over a third of the patients are under the age of 18. How do you feel about Singular status switch as a pharmacist?  How often do you counsel patients on products that recently switched to OTC?

For additional information, please see the news analysis in the Associated Press.

Click for more information from the FDA.
Image courtesy of [David Castillo Dominici]/FreeDigitalPhotos.Net

View original post

1 in 20 Americans Receive A Misdiagnosis Each Year


A recent study has looked at many of the outpatient and doctors office visits and found that approximately 5% of the time patients are misdiagnoses. Unwanted health consequences include delayed treatment or unnecessary treatment in the health care settings. Policy makers, healthcare organizations, and other shareholders now must figure out ways to minimize these diagnostic errors. How do you feel these misdiagnoses affects the trust of patients to medical professionals?

For additional information, please see the article in Medical Daily.

Click for more information in BMJ Quality and Safety.

Rates of Diabetic Complications Falling

A recently published study shows that there have been adecrease in all diabetic complications (heart attacks, strokes, amputations) within the past 20 years. These trends continued, even though more people are getting diagnosed with diabetes. The trend can be attributed to new medications and better screening for the disease. Do you agree with these trends? What have you seen among diabetic patients in your practice? Diabetic Lancet Device In Hand Stock Photo

For additional information, please see the article in Yahoo News.

Click for more information from the NEJM.

Image courtesy of [pat138241]/FreeDigitalPhotos.Net

Grass Pollen Allergy Drug Gets FDA Approval

ID-100226074An immunotherapy for grass allergies has been approved by the FDA for use in patients age 5 to 65. Merck’s drug, Grastek, is a sublingual tablet that has been available in the European market since 2006. It is an extract of Timothy Grass, the most common grass allergen in North America, and shows to be a promising particularly in the pediatric population. What are your expectations in terms of popularity of this agent when it comes to market?


For additional information, please see the article in Medscape.

Click for the approval letter from the FDA.

Image courtesy of [sakhorn38]/FreeDigitalPhotos.Net

The greatest site in all the land!